- Home
- CPRX vs BATRA Comparison
CPRX vs BATRA Comparison
Compare CPRX & BATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRX
- BATRA
- Stock Information
- Founded
- CPRX 2002
- BATRA 1991
- Country
- CPRX United States
- BATRA United States
- Employees
- CPRX N/A
- BATRA N/A
- Industry
- CPRX Biotechnology: Pharmaceutical Preparations
- BATRA Broadcasting
- Sector
- CPRX Health Care
- BATRA Industrials
- Exchange
- CPRX Nasdaq
- BATRA Nasdaq
- Market Cap
- CPRX 2.6B
- BATRA 2.9B
- IPO Year
- CPRX 2006
- BATRA N/A
- Fundamental
- Price
- CPRX $20.22
- BATRA $45.40
- Analyst Decision
- CPRX Strong Buy
- BATRA Strong Buy
- Analyst Count
- CPRX 5
- BATRA 3
- Target Price
- CPRX $33.20
- BATRA $58.00
- AVG Volume (30 Days)
- CPRX 1.5M
- BATRA 32.6K
- Earning Date
- CPRX 11-05-2025
- BATRA 11-05-2025
- Dividend Yield
- CPRX N/A
- BATRA N/A
- EPS Growth
- CPRX 183.96
- BATRA N/A
- EPS
- CPRX 1.65
- BATRA N/A
- Revenue
- CPRX $558,499,000.00
- BATRA $702,443,000.00
- Revenue This Year
- CPRX $16.51
- BATRA $14.16
- Revenue Next Year
- CPRX $9.58
- BATRA $3.97
- P/E Ratio
- CPRX $12.10
- BATRA N/A
- Revenue Growth
- CPRX 28.55
- BATRA 6.51
- 52 Week Low
- CPRX $19.15
- BATRA $38.67
- 52 Week High
- CPRX $26.58
- BATRA $50.50
- Technical
- Relative Strength Index (RSI)
- CPRX 48.86
- BATRA 41.00
- Support Level
- CPRX $19.66
- BATRA $44.98
- Resistance Level
- CPRX $20.42
- BATRA $46.22
- Average True Range (ATR)
- CPRX 0.66
- BATRA 0.86
- MACD
- CPRX 0.04
- BATRA -0.06
- Stochastic Oscillator
- CPRX 51.13
- BATRA 13.54
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
About BATRA Atlanta Braves Holdings Inc. Series A
Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.